PATENT CLAIM ANALYSIS

Application Number: 16273919
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-08
Patent Classification: ["514", "232500"]

Abstract:
The present invention provides methods and pharmaceutical compositions for the treatment or prevention of autophagy-related diseases, disorders, or conditions.

Claim (Index 12):
The method of  claim 10 , wherein the disease, disorder, or condition associated with alpha-1 antitrypsin deficiency is a disease of the liver.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 99.0
- Lexical Diversity: 1.1
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13985346', '14357039', '13392473', '14963137', '15494136']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.778482684385142
- 35 USC 102 Novelty (BERT): 0.5192636170211894
- Combined Prediction Score: 0.7525607776487467
- Mean Citation Score: 218.555008
- Max Citation Score: 298.6265
- Similarity Product: 215.20652734422688

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test